| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |